UTMD Utah Medical Products Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: UTMD

Price (delayed)

$65.21

Market cap

$207.63M

P/E Ratio

19.29

Dividend/share

$1.24

EPS

$3.38

Enterprise value

$120.43M

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 50
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 76

Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized ...

Highlights
The debt is down by 22% YoY and by 7% QoQ
The equity has grown by 2.8% YoY
Utah Medical Products's quick ratio has increased by 29% YoY but it has decreased by 24% from the previous quarter
UTMD's net income is down by 16% YoY and by 3.9% from the previous quarter
UTMD's P/E is 16% above its last 4 quarters average of 16.9 and 4.1% above its 5-year quarterly average of 18.8
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.utahmed.com
Peers: MMSI COO TFX JNJ

Key stats

What are the main financial stats of UTMD

UTMD stock price

How has the Utah Medical Products stock price performed over time
Intraday
-1.41%
1 week
-3.35%
1 month
1.09%
1 year
18.8%
YTD
16.53%
QTD
5.19%

Financial performance

How have Utah Medical Products's revenue and profit performed over time
Revenue
$37.53M
Gross profit
$21.75M
Operating income
$10.81M
Net income
$10.85M
Gross margin
57.9%
Net margin
28.9%
UTMD's net income is down by 16% YoY and by 3.9% from the previous quarter
The operating income has contracted by 16% YoY and by 5% from the previous quarter
The net margin is down by 12% YoY
Utah Medical Products's operating margin has decreased by 12% YoY and by 2.7% QoQ

Price vs fundamentals

How does UTMD's price correlate with its fundamentals

Growth

What is Utah Medical Products's growth rate over time

Valuation

What is Utah Medical Products stock price valuation
UTMD P/E details
P/E
19.29
P/B
1.73
P/S
5.53
EV/EBIT
8.97
EV/EBITDA
7.34
EV/Sales
3.21
UTMD's P/E is 16% above its last 4 quarters average of 16.9 and 4.1% above its 5-year quarterly average of 18.8
UTMD's EPS is down by 11% year-on-year and by 2.9% since the previous quarter
UTMD's price to book (P/B) is 27% lower than its 5-year quarterly average of 2.4 but 9% higher than its last 4 quarters average of 1.6
The equity has grown by 2.8% YoY
The stock's P/S is 12% above its last 4 quarters average of 5.0 but 4.9% below its 5-year quarterly average of 5.9
UTMD's revenue is down by 4.4% year-on-year and by 2.6% since the previous quarter

Efficiency

How efficient is Utah Medical Products business performance
Utah Medical Products's ROIC has decreased by 16% YoY and by 5% from the previous quarter
UTMD's ROE is down by 15% YoY and by 5% from the previous quarter
Utah Medical Products's return on assets has decreased by 14% YoY and by 4.3% QoQ
UTMD's ROS is down by 11% year-on-year and by 2.2% since the previous quarter

Dividends

What is UTMD's dividend history
Dividend details
DPS
$1.24
Dividend yield
1.89%
Payout ratio
36.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Utah Medical Products financials performed over time
Utah Medical Products's quick ratio has increased by 29% YoY but it has decreased by 24% from the previous quarter
The current ratio has grown by 28% YoY but it has contracted by 24% from the previous quarter
The debt is 100% lower than the equity
The debt is down by 22% YoY and by 7% QoQ
The equity has grown by 2.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.